Cadrenal Therapeutics Stock Predictions

Disrupting a Trillion-Dollar Industry

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Buy

CVKD
Cadrenal Therapeutics

Last Price:

$14.54

Seasonality Move:

-26.84%

7 Day Trial

ALL ACCESS PASS

$ 7

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio

Cadrenal Therapeutics Stock Forecast

Over the next 52 weeks, Cadrenal Therapeutics has on average historically risen by 36.8% based on the past 2 years of stock performance.
Cadrenal Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Cadrenal Therapeutics Stock Undervalued?

The current Cadrenal Therapeutics [CVKD] share price is $15.03. The Score for CVKD is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
CVKD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Cadrenal Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Cadrenal Therapeutics has on average historically risen by 36.8% based on the past 2 years of stock performance.

Cadrenal Therapeutics Stock Rating

Buy

Cadrenal Therapeutics (CVKD) is a Buy

Is Cadrenal Therapeutics overpriced?

Cadrenal Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Cadrenal Therapeutics Stock Price History

Is CVKD stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CVKD is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

cadrenal.com

52-Week Data

52-Week High:

22.90

52-Week Low:

5.70

Prediction Charts

Market Cap:

29.6M

Price in USD:

15.03

Volume:

10.5K

Beta:

1.42

Technical Analysis

SMA50:

16.66

SMA100:

17.35

SMA200:

14.80

52-Wk Change:

142.79%

Stock Predictions

Is Cadrenal Therapeutics stock public?

Yes, Cadrenal Therapeutics is a publicly traded company.
What is the Cadrenal Therapeutics stock quote today?

The Cadrenal Therapeutics stock price is 15.03 USD today.
How to buy Cadrenal Therapeutics stock online?

You can buy Cadrenal Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
May-5	16.41	16.34	16.75	16.05
May-6	16.20	15.68	16.34	15.61
May-7	15.88	16.28	16.31	15.29
May-8	16.50	15.50	16.50	15.30
May-9	15.97	14.45	15.97	14.20
May-12	14.64	13.38	15.83	13.27
May-13	13.19	14.79	14.95	13.10
May-14	13.94	14.14	14.67	13.57
May-15	14.08	15.14	15.31	13.76
May-16	15.16	15.50	16.25	15.16
May-19	15.44	15.35	15.63	14.80
May-20	15.45	15.68	15.74	14.96
May-21	15.51	15.70	15.85	15.08
May-22	15.63	15.03	15.90	14.80

Cadrenal Therapeutics Earnings

Cadrenal Therapeutics Earnings Report: Per Share Cadrenal Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cadrenal Therapeutics Forecast Revenue Growth

Cadrenal Therapeutics Stock Analysis: Historical quarterly revenues per share for Cadrenal Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $2.54 per share.

* Cadrenal Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.